Ekuinas makes maiden pharma investment

Ekuinas chief executive officer Syed Yasir Arafat Syed Abd Kadir (pic) said their entry into the healthcare and pharmaceutical space was timely as it looked to capitalise on global megatrends and demographic shifts amid the emergence of Covid-19.

KUALA LUMPUR: Ekuiti Nasional Bhd (Ekuinas) has made its maiden investment into the pharmaceutical industry with the acquisition of a controlling stake in Medispec (M) Sdn Bhd, based on an enterprise value of RM88.5mil.

The government-linked private equity fund management company said it was highly cognisant of the macro themes at play, which led to its entry into the industry.